Nishimura Eiji, Sakihama Toshiko, Setoguchi Ruka, Tanaka Koichi, Sakaguchi Shimon
Department of Experimental Pathology, Institute for Frontier Medical Sciences, Faculty of Medicine, Kyoto University, Japan.
Int Immunol. 2004 Aug;16(8):1189-201. doi: 10.1093/intimm/dxh122. Epub 2004 Jul 5.
Naturally arising CD25(+)CD4(+) regulatory T (T(R)) cells can be exploited to establish immunologic tolerance to non-self antigens. In vivo exposure of CD25(+)CD4(+) T cells from normal naive mice to alloantigen in a T cell-deficient environment elicited spontaneous expansion of alloantigen-specific CD25(+)CD4(+) T(R) cells, which suppressed allograft rejection mediated by subsequently transferred naive T cells, leading to long-term graft tolerance. The expanded T(R) cells, which became CD25(low) in the absence of other T cells, stably sustained suppressive activity, maintained expression levels of other T(R) cell-associated molecules, including Foxp3, CTLA-4 and GITR, and could adoptively transfer tolerance to normal mice. Furthermore, specific removal of the T(R) cells derived from originally transferred CD25(+)CD4(+) T(R) cells evoked graft rejection in the long-term tolerant mice, indicating that any T(R) cells deriving from CD25(-)CD4(+) naive T cells minimally contribute to graft tolerance and that natural T(R) cells are unable to infectiously confer significant suppressive activity to other T cells. Similar antigen-specific expansion of T(R) cells can also be achieved in vitro by stimulating naturally present CD25(+)CD4(+) T cells with alloantigen in the presence of IL-2. The expanded CD25(+)CD4(+) T cells potently suppressed even secondary MLR in vitro and, by in vivo transfer, established antigen-specific long-term graft tolerance. Thus, in vivo or in vitro, direct or indirect ways of antigen-specific expansion of naturally arising Foxp3(+)CD25(+)CD4(+) T(R) cells can establish antigen-specific dominant tolerance to non-self antigens, and would also be instrumental in re-establishing self-tolerance in autoimmune disease and antigen-specific negative control of pathological immune responses.
天然产生的CD25(+)CD4(+)调节性T(T(R))细胞可用于建立对非自身抗原的免疫耐受。在T细胞缺陷环境中,将正常未致敏小鼠的CD25(+)CD4(+) T细胞体内暴露于同种异体抗原,可引发同种异体抗原特异性CD25(+)CD4(+) T(R)细胞的自发扩增,该细胞可抑制随后转移的未致敏T细胞介导的同种异体移植排斥反应,从而导致长期的移植耐受。在没有其他T细胞的情况下,扩增后的T(R)细胞CD25表达降低,但仍稳定维持抑制活性,保持包括Foxp3、CTLA-4和GITR在内的其他T(R)细胞相关分子的表达水平,并可将耐受性过继转移至正常小鼠。此外,特异性去除最初转移的CD25(+)CD4(+) T(R)细胞衍生的T(R)细胞,可在长期耐受的小鼠中引发移植排斥反应,这表明源自CD25(-)CD4(+)未致敏T细胞的任何T(R)细胞对移植耐受的贡献极小,且天然T(R)细胞无法将显著的抑制活性感染性地赋予其他T细胞。通过在IL-2存在的情况下用同种异体抗原刺激天然存在的CD25(+)CD4(+) T细胞,也可在体外实现T(R)细胞的类似抗原特异性扩增。扩增后的CD25(+)CD4(+) T细胞在体外甚至能有效抑制二次混合淋巴细胞反应,并通过体内转移建立抗原特异性长期移植耐受。因此,无论是体内还是体外,天然产生的Foxp3(+)CD25(+)CD4(+) T(R)细胞的抗原特异性扩增的直接或间接方式均可建立对非自身抗原的抗原特异性显性耐受,这在自身免疫性疾病中重新建立自身耐受以及对病理性免疫反应进行抗原特异性阴性控制方面也将发挥作用。